|
26 Companies |
|
24 Products |
|
24 Products |
|
22 Mechanisms of Action |
|
2 Trials |
|
625 News |
|
| «12345678910111213» |
- | Trial completion: MIST Ultrasound Therapy Compared to United Kingdom Standard Care for the Treatment of Non-healing Venous Leg Ulcers (clinicaltrials.gov) - Aug 27, 2015
P=N/A, N=47, Completed, Sponsor: Cardiff and Vale University Health Board
Active, not recruiting --> Completed
- Trial completion, Trial initiation date, Trial primary completion date: Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment (clinicaltrials.gov) - Aug 26, 2015
P1/2, N=30, Completed, Sponsor: Hospital Universitario Central de Asturias
Active, not recruiting --> Completed Recruiting --> Completed | Initiation date: Dec 2011 --> Nov 2007 | Trial primary completion date: Dec 2012 --> Dec 2008
- Enrollment change: A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers (clinicaltrials.gov) - Aug 20, 2015
P4, N=0, Withdrawn, Sponsor: Organogenesis
Recruiting --> Completed | Initiation date: Dec 2011 --> Nov 2007 | Trial primary completion date: Dec 2012 --> Dec 2008 N=15 --> 0
- ||||| Trial initiation date, Trial primary completion date: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro (clinicaltrials.gov) - Aug 13, 2015
P2/3, N=250, Not yet recruiting, Sponsor: Tissue Therapies Ltd.
N=15 --> 0 Initiation date: Jan 2019 --> Jan 2016 | Trial primary completion date: Dec 2021 --> Jun 2017
- | Trial completion, Enrollment change, Trial primary completion date: Askina Calgitrol Paste Diabetic Foot Ulcers (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=22, Completed, Sponsor: BBraun Medical SAS
Initiation date: Jan 2019 --> Jan 2016 | Trial primary completion date: Dec 2021 --> Jun 2017 Recruiting --> Completed | N=35 --> 22 | Trial primary completion date: Dec 2014 --> Jul 2014
- Trial completion: PRP-2012: Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers (clinicaltrials.gov) - Aug 12, 2015
P1/2, N=40, Completed, Sponsor: Basque Health Service
Recruiting --> Completed | N=35 --> 22 | Trial primary completion date: Dec 2014 --> Jul 2014 Recruiting --> Completed
- ||| nitric oxide (EDX110) / Edixomed
Enrollment closed: ProNOx1: Nitric Oxide Generating Gel Dressing in Patients With Diabetic Foot Ulcers (clinicaltrials.gov) - Aug 11, 2015
P1/2, N=140, Active, not recruiting, Sponsor: Edixomed Ltd
Recruiting --> Completed Recruiting --> Active, not recruiting
- doxycycline / Generic mfg.
Enrollment open: Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana (clinicaltrials.gov) - Aug 11, 2015
P2, N=200, Recruiting, Sponsor: Kwame Nkrumah University of Science and Technology
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Trial completion: Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers (clinicaltrials.gov) - Aug 11, 2015
P4, N=29, Completed, Sponsor: Derma Sciences, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial completion, Enrollment change: SACRESS: Prevention of Sacral Pressure Ulcers With Preventive Dressings (clinicaltrials.gov) - Jul 21, 2015
P=N/A, N=253, Completed, Sponsor: Maastricht University Medical Center
Active, not recruiting --> Completed Recruiting --> Completed | N=914 --> 253
- Enrollment change, Trial withdrawal, Head-to-Head: Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers. (clinicaltrials.gov) - Jul 16, 2015
P3, N=0, Withdrawn, Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda.
Recruiting --> Completed | N=914 --> 253 N=92 --> 0 | Not yet recruiting --> Withdrawn
- Trial completion: CHEXU 01: Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU When Using Fast Gelling Dressing as Intended. (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=25, Completed, Sponsor: Molnlycke Health Care AB
N=92 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- Enrollment closed: Post Market Clinical Follow-up Investigation to Evaluate Performance and Safety on Pressure Ulcers, PU, When Using Exufiber as Intended (clinicaltrials.gov) - Jul 8, 2015
P=N/A, N=20, Active, not recruiting, Sponsor: Molnlycke Health Care AB
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Phase classification, Trial primary completion date: A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs (clinicaltrials.gov) - Jul 8, 2015
P=N/A, N=20, Recruiting, Sponsor: Smith & Nephew Medical Ltd
Recruiting --> Active, not recruiting Phase classification: P4 --> P=N/A | Trial primary completion date: Feb 2015 --> Aug 2015
- Trial primary completion date: CONDUCT I: NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 30, 2015
P=N/A, N=30, Recruiting, Sponsor: Amniox Medical, Inc.
Phase classification: P4 --> P=N/A | Trial primary completion date: Feb 2015 --> Aug 2015 Trial primary completion date: May 2015 --> Jun 2016
- Biomarker, Trial completion, Enrollment change, Trial primary completion date: MOJITO: Predictive of Biomarkers of Healing in Chronic Venous Ulceration of the Lower Limb (clinicaltrials.gov) - Jun 30, 2015
P=N/A, N=28, Completed, Sponsor: Imperial College London
Trial primary completion date: May 2015 --> Jun 2016 Recruiting --> Completed | N=40 --> 28 | Trial primary completion date: Feb 2015 --> Jun 2015
- Enrollment change: TELEPUPPS: Pressure Ulcer Prevention for SCI Using a Tele Home Program (clinicaltrials.gov) - Jun 26, 2015
P=N/A, N=0, Withdrawn, Sponsor: Department of Veterans Affairs
Recruiting --> Completed | N=40 --> 28 | Trial primary completion date: Feb 2015 --> Jun 2015 N=230 --> 0
- Trial primary completion date: SAS-FOOT: Impact of Sleep Apnea on Diabetic Foot Wound. (clinicaltrials.gov) - Jun 23, 2015
P=N/A, N=60, Recruiting, Sponsor: AGIR à Dom
N=230 --> 0 Trial primary completion date: Apr 2014 --> Apr 2016
- | Trial completion, Trial primary completion date: V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds (clinicaltrials.gov) - Jun 18, 2015
P=N/A, N=20, Completed, Sponsor: St. Luke's-Roosevelt Hospital Center
Trial primary completion date: Apr 2014 --> Apr 2016 Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> May 2015
- | Enrollment closed: Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 15, 2015
P4, N=30, Active, not recruiting, Sponsor: Derma Sciences, Inc.
Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> May 2015 Recruiting --> Active, not recruiting
- Trial primary completion date: PUPS: Pressure Ulcer Prevention Study in SCI (clinicaltrials.gov) - Jun 11, 2015
P3, N=170, Active, not recruiting, Sponsor: University of Southern California
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2013 --> Sep 2015
- Trial suspension, Trial primary completion date: Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=30, Suspended, Sponsor: University of Michigan
Trial primary completion date: Jun 2013 --> Sep 2015 Recruiting --> Suspended | Trial primary completion date: Aug 2016 --> Aug 2017
- Enrollment change, Trial primary completion date: Evaluation of Fluorescence-image Guided Wound Assessment vs. Standard Practice (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=77, Enrolling by invitation, Sponsor: University Health Network, Toronto
Recruiting --> Suspended | Trial primary completion date: Aug 2016 --> Aug 2017 N=60 --> 77 | Trial primary completion date: Mar 2015 --> Dec 2015
- || Enrollment change, Trial primary completion date: Use of dHACM in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=120, Recruiting, Sponsor: MiMedx Group, Inc.
N=60 --> 77 | Trial primary completion date: Mar 2015 --> Dec 2015 N=90 --> 120 | Trial primary completion date: Mar 2015 --> Jan 2016
- vildagliptin / Generic mfg.
Trial primary completion date: DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes (clinicaltrials.gov) - Jun 11, 2015
P4, N=106, Active, not recruiting, Sponsor: Second University of Naples
N=90 --> 120 | Trial primary completion date: Mar 2015 --> Jan 2016 Trial primary completion date: Dec 2011 --> Dec 2015
- Trial primary completion date, Biopsy: Obtaining and Storing Standard of Care Wound Biopsies for Immediate or Future Wound-Related Scientific Study (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=5, Recruiting, Sponsor: Southwest Regional Wound Care Center
Trial primary completion date: Dec 2011 --> Dec 2015 Trial primary completion date: Mar 2015 --> Mar 2016
- ||||| Trial initiation date, Trial primary completion date: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro (clinicaltrials.gov) - Jun 11, 2015
P2/3, N=250, Not yet recruiting, Sponsor: Tissue Therapies Ltd.
Trial primary completion date: Mar 2015 --> Mar 2016 Initiation date: Nov 2013 --> Jan 2019 | Trial primary completion date: Dec 2015 --> Dec 2021
- gentamicin sulfate / Generic mfg.
Enrollment change, Trial termination: Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 11, 2015
P1/2, N=9, Terminated, Sponsor: Royer Biomedical, Inc.
Initiation date: Nov 2013 --> Jan 2019 | Trial primary completion date: Dec 2015 --> Dec 2021 N=86 --> 9 | Recruiting --> Terminated
- Trial completion, Phase classification, Trial primary completion date: EZCast-DFU Study With Portal for Application of Topical Medications (clinicaltrials.gov) - Jun 10, 2015
P1, N=4, Completed, Sponsor: University of Miami
N=86 --> 9 | Recruiting --> Terminated Recruiting --> Completed | Phase classification: P4 --> P1 | Trial primary completion date: Oct 2015 --> Jun 2015
- Trial completion, Enrollment change, Trial primary completion date: BION Active Seating for Pressure Ulcer Prevention (clinicaltrials.gov) - Jun 3, 2015
P1, N=3, Completed, Sponsor: University of Southern California
Recruiting --> Completed | Phase classification: P4 --> P1 | Trial primary completion date: Oct 2015 --> Jun 2015 Active, not recruiting --> Completed | N=30 --> 3 | Trial primary completion date: Sep 2009 --> Dec 2008
- | Enrollment closed: AIRPEDIA: Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management (clinicaltrials.gov) - May 28, 2015
P2/3, N=64, Active, not recruiting, Sponsor: University Hospital, Grenoble
Active, not recruiting --> Completed | N=30 --> 3 | Trial primary completion date: Sep 2009 --> Dec 2008 Recruiting --> Active, not recruiting
- Trial completion, Trial primary completion date: Comparison of Resin Salve and Octenidine in Patients With Neuropathic Diabetic Foot Ulcers (clinicaltrials.gov) - May 27, 2015
P=N/A, N=35, Completed, Sponsor: Janne J. Jokinen
Recruiting --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: Nov 2014 --> May 2015
- Enrollment change, Trial withdrawal: Implanted Gluteal Stimulation System for Pressure Sore Prevention (clinicaltrials.gov) - May 22, 2015
P=N/A, N=0, Withdrawn, Sponsor: Department of Veterans Affairs
Recruiting --> Completed | Trial primary completion date: Nov 2014 --> May 2015 N=10 --> 0 | Terminated --> Withdrawn
- Enrollment change: A Randomized, Controlled Trial of Autologous Platelet Gel Treatment in Diabetic Foot Ulcers (clinicaltrials.gov) - May 21, 2015
P4, N=0, Withdrawn, Sponsor: St. Michael's Hospital, Toronto
N=10 --> 0 | Terminated --> Withdrawn N=50 --> 0
- ||||| Enrollment closed: Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247 (clinicaltrials.gov) - May 19, 2015
P3, N=440, Active, not recruiting, Sponsor: Smith & Nephew, Inc.
N=50 --> 0 Enrolling by invitation --> Active, not recruiting
- Trial completion, Enrollment change: Proof-of-concept Study for Bioimpedance Based Monitoring of Venous Ulcers During Galvanic Stimulation (clinicaltrials.gov) - May 13, 2015
P=N/A, N=6, Completed, Sponsor: Tampere University Hospital
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed | N=10 --> 6
- Enrollment change: The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospective Randomized Double-Blinded Trial (clinicaltrials.gov) - May 12, 2015
P=N/A, N=0, Withdrawn, Sponsor: TEI Biosciences Inc.
Active, not recruiting --> Completed | N=10 --> 6 N=10 --> 0
- Trial completion: Pressure Ulcer Prevention in Intensive Care Unit (ICU) (clinicaltrials.gov) - May 12, 2015
P=N/A, N=440, Completed, Sponsor: Melbourne Health
N=10 --> 0 Recruiting --> Completed
- Januvia (sitagliptin) / Merck (MSD)
Enrollment change, Trial termination, Trial primary completion date: Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - May 5, 2015
P4, N=1, Terminated, Sponsor: Georgetown University
Recruiting --> Completed N=250 --> 1 | Recruiting --> Terminated | Trial primary completion date: Jan 2017 --> Jan 2015; Terminated by the sponsor due to slow enrollment
- Trial primary completion date: Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study (clinicaltrials.gov) - Apr 29, 2015
P=N/A, N=50, Recruiting, Sponsor: Temple University
N=250 --> 1 | Recruiting --> Terminated | Trial primary completion date: Jan 2017 --> Jan 2015; Terminated by the sponsor due to slow enrollment Trial primary completion date: Oct 2012 --> Oct 2016
- Enrollment closed: V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds (clinicaltrials.gov) - Apr 29, 2015
P=N/A, N=20, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Trial primary completion date: Oct 2012 --> Oct 2016 Recruiting --> Active, not recruiting
- ||| Trial initiation date, Trial primary completion date: Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds (clinicaltrials.gov) - Apr 19, 2015
P2, N=72, Recruiting, Sponsor: MediWound Ltd
Recruiting --> Active, not recruiting Initiation date: May 2014 --> Aug 2014 | Trial primary completion date: May 2015 --> Dec 2015
- Trial primary completion date: Potential Research Study Participant Registry (clinicaltrials.gov) - Apr 16, 2015
P=N/A, N=200, Recruiting, Sponsor: University of California, Davis
Initiation date: May 2014 --> Aug 2014 | Trial primary completion date: May 2015 --> Dec 2015 Trial primary completion date: Jan 2015 --> Jan 2025
- Trial completion, Phase classification, Enrollment change, Trial primary completion date: Reference Nurse Program for Pressure Ulcers in Primary Care (clinicaltrials.gov) - Apr 16, 2015
P2, N=58, Completed, Sponsor: Basque Health Service
Trial primary completion date: Jan 2015 --> Jan 2025 Active, not recruiting --> Completed | Phase classification: P3 --> P2 | N=124 --> 58 | Trial primary completion date: May 2014 --> Sep 2014
- Locilex (pexiganan acetate) / PLx Pharma Inc
Trial primary completion date, Head-to-Head: OneStep-2: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 15, 2015
P3, N=180, Recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Active, not recruiting --> Completed | Phase classification: P3 --> P2 | N=124 --> 58 | Trial primary completion date: May 2014 --> Sep 2014 Trial primary completion date: Mar 2015 --> Sep 2015
- Locilex (pexiganan acetate) / PLx Pharma Inc
Trial primary completion date, Head-to-Head: OneStep-1: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 15, 2015
P3, N=180, Recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Trial primary completion date: Mar 2015 --> Sep 2015 Trial primary completion date: Mar 2015 --> Sep 2015
- || Trial primary completion date, HEOR: Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=224, Recruiting, Sponsor: TEI Biosciences Inc.
Trial primary completion date: Mar 2015 --> Sep 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation (clinicaltrials.gov) - Apr 15, 2015
P1/2, N=240, Recruiting, Sponsor: Medical University of South Carolina
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Aug 2013 --> Dec 2015
- Trial primary completion date: Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=5, Recruiting, Sponsor: KLOX Technologies Inc.
Trial primary completion date: Aug 2013 --> Dec 2015 Trial primary completion date: Mar 2015 --> Oct 2015
- Trial primary completion date: Safety Evaluation of the KLOX BioPhotonic System in Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=10, Recruiting, Sponsor: KLOX Technologies Inc.
Trial primary completion date: Mar 2015 --> Oct 2015 Trial primary completion date: May 2015 --> Dec 2015